Clinical Trial Update: Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessing the safety and tolerability of FITC-conjugated adalimumab administered during confocal laser endomicroscopy in Crohn's disease has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Adalimumab (FITC-conjugated) (adalimumab)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED